Several other findings have demonstrated that integrins, transmembrane receptors involved in cell adhesion to ECM, are important regulators of tumor initiation and progression, cancer stemness, and drug resistance, but the available data are often conflicting [45]. The gene discussed is NRP1; the disease is cancer.